España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Savara
SVRA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.23
0.00
0.00%
Pre-Market: Dec 20, 4:01 PM EDT
Get Report
Comment
Savara (SVRA) Forecast
News
Earnings
Savara (SVRA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Savara (NASDAQ:SVRA) Stock
Savara Stock (NASDAQ: SVRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
Wells Fargo Initiates Coverage On Savara with...
Benzinga Newsdesk
Thursday, December 19, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wednesday, December 18, 2024
Savara Initiates Rolling Submission Of Biolog...
Benzinga Newsdesk
Wednesday, November 13, 2024
Savara shares are trading lower after Evercor...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Savara, ...
Benzinga Newsdesk
Evercore ISI Group Downgrades Savara to In-Li...
Benzinga Newsdesk
Tuesday, November 12, 2024
Savara Q3 EPS $(0.11), Inline
Benzinga Newsdesk
Tuesday, October 08, 2024
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Tuesday, October 01, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Friday, September 27, 2024
Savara Announces Expanded Access Program For ...
Benzinga Newsdesk
Monday, September 09, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Sunday, Savara Unveils Phase 3 IMPAL...
Benzinga Newsdesk
Thursday, August 15, 2024
Savara Announces Acceptance Of Abstract For P...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Tuesday, August 13, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Monday, August 12, 2024
Savara Q2 2024 Adj EPS $(0.12) Misses $(0.11)...
Benzinga Newsdesk
Friday, June 28, 2024
Savara Announces Pricing Of $100M Underwritte...
Benzinga Newsdesk
Thursday, June 27, 2024
Guggenheim Maintains Buy on Savara, Raises Pr...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Savara, ...
Benzinga Newsdesk
Wednesday, June 26, 2024
Oppenheimer Maintains Outperform on Savara, R...
Benzinga Newsdesk
Savara shares are trading lower, pulling back...
Benzinga Newsdesk
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
Vandana Singh
Savara shares are trading higher after the co...
Benzinga Newsdesk
Savara Inc Announces Phase 3 Trial Results fo...
Benzinga Newsdesk
Savara's Phase 3 IMPALA-2 Trial Of Molgramost...
Benzinga Newsdesk
Tuesday, May 21, 2024
Oppenheimer Maintains Outperform on Savara, R...
Benzinga Newsdesk
Monday, May 20, 2024
Reported Sunday, Savara And Trillium Health P...
Benzinga Newsdesk
Thursday, May 16, 2024
Evercore ISI Group Maintains Outperform on Sa...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Thursday, May 09, 2024
Savara Q1 2024 Adj EPS $(0.11) Misses $(0.10)...
Benzinga Newsdesk
Monday, May 06, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, April 19, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, April 18, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, April 08, 2024
Savara To Present New Data On Autoimmune Pulm...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Thursday, March 07, 2024
Savara Q4 EPS $(0.09) Beats $(0.10) Estimate
Happy Mohamed
Monday, March 04, 2024
Piper Sandler Maintains Overweight on Savara,...
Benzinga Newsdesk
Friday, February 16, 2024
On Feb 13, Savara Inc Entered Agreement With ...
Benzinga Newsdesk
Thursday, February 15, 2024
JMP Securities Initiates Coverage On Savara w...
Benzinga Newsdesk
Tuesday, January 16, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tuesday, January 02, 2024
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor
Thursday, December 21, 2023
Savara Introduces aPAP ClearPath, a GM-CSF Au...
Benzinga Newsdesk
Monday, November 13, 2023
HC Wainwright & Co. Reiterates Buy on Savara,...
Benzinga Newsdesk
Thursday, November 09, 2023
Savara Q3 EPS $(0.10) Misses $(0.07) Estimate
Benzinga Newsdesk
Wednesday, November 08, 2023
5 OTC Stocks With The Potential To Explode In 2024
Chris Bibey
Tuesday, November 07, 2023
Guggenheim Initiates Coverage On Savara with ...
Benzinga Newsdesk
Monday, August 14, 2023
HC Wainwright & Co. Maintains Buy on Savara, ...
Benzinga Newsdesk
Thursday, August 10, 2023
Savara Q2 EPS $(0.07) Down From $(0.06) YoY
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch